These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 19941657)
1. Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Goldsmith KA; Dyer MT; Schofield PM; Buxton MJ; Sharples LD Health Qual Life Outcomes; 2009 Nov; 7():96. PubMed ID: 19941657 [TBL] [Abstract][Full Text] [Related]
2. Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease. Goldsmith KA; Dyer MT; Buxton MJ; Sharples LD Health Qual Life Outcomes; 2010 Jun; 8():54. PubMed ID: 20525323 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires. Höfer S; Benzer W; Schüssler G; von Steinbüchel N; Oldridge NB Qual Life Res; 2003 Mar; 12(2):199-212. PubMed ID: 12639066 [TBL] [Abstract][Full Text] [Related]
4. Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework. Wijeysundera HC; Tomlinson G; Norris CM; Ghali WA; Ko DT; Krahn MD Med Decis Making; 2011; 31(3):481-93. PubMed ID: 21127316 [TBL] [Abstract][Full Text] [Related]
5. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446 [TBL] [Abstract][Full Text] [Related]
6. Seattle Angina Pectoris Questionnaire and Canadian Cardiovascular Society Angina Categories in the Assessment of Total Coronary Atherosclerotic Burden. Guimarães WVN; Nicz PFG; Garcia-Garcia HM; Abizaid A; Santos LM; Rosa VE; Ribeiro MH; Mehta S; Ribeiro E; Lemos PA; Brito FS; Hajjar L; Filho RK; Campos CM Am J Cardiol; 2021 Aug; 152():43-48. PubMed ID: 34175106 [TBL] [Abstract][Full Text] [Related]
7. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease. Li C; Dou L; Fu Q; Li S Health Qual Life Outcomes; 2023 Jul; 21(1):64. PubMed ID: 37400827 [TBL] [Abstract][Full Text] [Related]
8. Estimating utility data from clinical indicators for patients with stable angina. Longworth L; Buxton MJ; Sculpher M; Smith DH Eur J Health Econ; 2005 Dec; 6(4):347-53. PubMed ID: 16193322 [TBL] [Abstract][Full Text] [Related]
9. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease. Bae E; Choi SE; Lee H; Shin G; Kang D BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387 [TBL] [Abstract][Full Text] [Related]
10. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Kontodimopoulos N; Argiriou M; Theakos N; Niakas D Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544 [TBL] [Abstract][Full Text] [Related]
11. Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature. Wijeysundera HC; Farshchi-Zarabi S; Witteman W; Bennell MC Clinicoecon Outcomes Res; 2014; 6():253-68. PubMed ID: 24876788 [TBL] [Abstract][Full Text] [Related]
12. Validation of the EQ-5D in patients with a history of acute coronary syndrome. Ellis JJ; Eagle KA; Kline-Rogers EM; Erickson SR Curr Med Res Opin; 2005 Aug; 21(8):1209-16. PubMed ID: 16083530 [TBL] [Abstract][Full Text] [Related]
13. Validation of the Seattle angina questionnaire in women with ischemic heart disease. Patel KK; Arnold SV; Chan PS; Tang Y; Jones PG; Guo J; Buchanan DM; Qintar M; Decker C; Morrow DA; Spertus JA Am Heart J; 2018 Jul; 201():117-123. PubMed ID: 29772387 [TBL] [Abstract][Full Text] [Related]
14. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. Moore A; Young CA; Hughes DA Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280 [TBL] [Abstract][Full Text] [Related]
15. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253 [TBL] [Abstract][Full Text] [Related]
16. [EuroQol-5D FOR quality of life assessment in cardiac rehabilitation]. Balestroni G; Omarini G; Omarini P; Zotti AM G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B56-62. PubMed ID: 18575359 [TBL] [Abstract][Full Text] [Related]
17. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III. Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004 [TBL] [Abstract][Full Text] [Related]
18. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Hurst NP; Kind P; Ruta D; Hunter M; Stubbings A Br J Rheumatol; 1997 May; 36(5):551-9. PubMed ID: 9189057 [TBL] [Abstract][Full Text] [Related]
19. Depression and chest pain in patients with coronary artery disease. Hayek SS; Ko YA; Awad M; Del Mar Soto A; Ahmed H; Patel K; Yuan M; Maddox S; Gray B; Hajjari J; Sperling L; Shah A; Vaccarino V; Quyyumi AA Int J Cardiol; 2017 Mar; 230():420-426. PubMed ID: 28041701 [TBL] [Abstract][Full Text] [Related]
20. Validation of the EuroQol questionnaire in cardiac rehabilitation. Schweikert B; Hahmann H; Leidl R Heart; 2006 Jan; 92(1):62-7. PubMed ID: 15797936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]